# 3D-ASL and TDD-MRI for True Progression and Pseudoprogression After Glioma Surgery

> **NCT07687277** · — · ACTIVE_NOT_RECRUITING · sponsor: **Lanzhou University Second Hospital** · enrollment: 75 (actual)

## Conditions studied

- Glioma
- Brain Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Multiparametric MRI (3D-ASL and TDD-MRI)

## Key facts

- **NCT ID:** NCT07687277
- **Lead sponsor:** Lanzhou University Second Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-07-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687277, "3D-ASL and TDD-MRI for True Progression and Pseudoprogression After Glioma Surgery". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07687277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*